吡喹酮诊断性治疗疑似脑囊尾蚴病的临床应用
[Clinical application of diagnostic therapy of praziquantel for suspected cere- bral cysticercosis].
作者信息
Li Yan, Sun Li, Chen Chuang, Yang Chun-mei
出版信息
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2015 Oct;27(5):517-9.
OBJECTIVE
To explore the clinical application value of diagnostic therapy of praziquantel for suspected cerebral cysticercosis.
METHODS
The suspected cerebral cysticercosis patients were collected and treated with the diagnostic therapy [praziquantel, 50 mg/(kg · d)], and followed up for 1-2 years.
RESULTS
Totally 94 suspected cerebral cysticercosis patients were collected. After the diagnostic therapy, 78 (82.98%) cases were confirmed as cerebral cysticercosis, 13 (13.83%) were diagnosed as other diseases, and 3 (3.19%) were not definitely diagnosed.
CONCLUSION
The diagnostic therapy for suspected cerebral cysticercosis can reduce or avoid the missed diagnosis and misdiagnosis in some atypical cerebral cysticercosis patients.
目的
探讨吡喹酮诊断性治疗疑似脑囊尾蚴病的临床应用价值。
方法
收集疑似脑囊尾蚴病患者，采用诊断性治疗[吡喹酮，50mg/(kg·d)]，并随访1-2年。
结果
共收集94例疑似脑囊尾蚴病患者。诊断性治疗后，78例(82.98%)确诊为脑囊尾蚴病，13例(13.83%)诊断为其他疾病，3例(3.19%)未明确诊断。
结论
疑似脑囊尾蚴病的诊断性治疗可减少或避免部分非典型脑囊尾蚴病患者的漏诊和误诊。
Zotero 插件